By GulfInside | Abu Dhabi | October 21, 2026
Abu Dhabi has outlined how artificial intelligence systems might one day be authorised to carry out defined clinical tasks. The Department of Health – Abu Dhabi (DoH) announced its AI Clinician Framework at the Abu Dhabi Future Health Summit, placing patient safety and physician oversight at the centre of the proposed approach.
The announcement is an important regulatory development, but it should not be mistaken for a decision to replace doctors with autonomous AI systems today. The framework lays the groundwork for research, evaluation and future policies.
What does the framework propose?
Rather than granting a broad approval to any AI tool, the approach assesses competence against specific clinical activities. A system seeking to perform more complex or wider-ranging work would need stronger supporting evidence. Safeguards include oversight by physicians, accountability and referral to a doctor when appropriate.
The DoH says future policies and standards will identify which activities might be authorised, what evidence would be required and the thresholds systems would need to meet.
Why this matters for healthcare
AI is already being studied for applications ranging from administrative support to interpreting clinical information. Moving toward an AI system that can perform a clinical activity raises different questions: who is accountable, how errors are detected and whether performance holds up across diverse patient groups.
By setting expectations before wider clinical use, regulators can give researchers clearer goals while making safety evidence a prerequisite rather than an afterthought.
Readers comparing everyday AI assistants can use our ChatGPT and Gemini guide, which discusses accuracy checks and privacy. Consumer assistant features should not be confused with the clinical authorization process described here.
What happens next?
Research under the framework is expected to take place within Abu Dhabi’s ‘living lab’ model, using connected healthcare infrastructure and structured clinical research pathways. The DoH will need to develop the supporting rules that translate the framework into specific authorisation decisions.
Questions patients may have
Can an AI system now independently treat patients in Abu Dhabi?
The announcement establishes a framework for research and possible future authorisation. It does not establish blanket permission for independent AI treatment.
Will a human doctor remain involved?
The DoH says physician oversight, accountability and referrals are part of the safeguards.
What evidence will AI clinicians need?
Evidence requirements will depend on the clinical tasks proposed; more extensive clinical scope would require stronger demonstrations of competence.
